aluminum sulfate has been researched along with naltrexone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khorshidvand, Z; Mohammadzadeh, H; Shahabi, S; Tappeh, KH | 1 |
| Azizi, H; Mazloomi, E; Mohammadzadeh, H; Seyedi, S; Shahabi, S; Tappeh, KH | 1 |
| Daryani, A; Hazrati Tappeh, K; Khorshidvand, Z; Mohamadzade, H; Shahabi, S | 1 |
| Azimi, A; Azizi, H; Bazi, A; Khatami, M; Mirzaeei, H; Mirzapour, A; Nahavandi, KH; Nasiri, AA; Yaghoobi, H | 1 |
4 other study(ies) available for aluminum sulfate and naltrexone
| Article | Year |
|---|---|
A novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb/c murine model.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Antigens, Protozoan; Female; Immunity, Humoral; Immunoglobulin G; Mice; Mice, Inbred BALB C; Models, Animal; Naltrexone; Protozoan Vaccines; Toxoplasma; Vaccination | 2013 |
A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Immunoglobulin G; Interferon-gamma; Interleukin-5; Lymphocytes; Malaria Vaccines; Male; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Plasmodium berghei | 2014 |
Mixture of Alum--Naloxone and Alum--Naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB /c mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Protozoan; Cell Proliferation; Cytokines; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Naltrexone; Peritoneal Cavity; Protozoan Vaccines; Specific Pathogen-Free Organisms; Toxoplasma; Toxoplasmosis, Animal | 2016 |
Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Helminth; Enzyme-Linked Immunosorbent Assay; Fasciola hepatica; Fascioliasis; Female; Immunity, Cellular; Immunization; Immunoglobulin G; Interferon-gamma; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Naltrexone; Random Allocation; Sheep; Th1 Cells; Viral Vaccines | 2018 |